Alta Capital Management LLC decreased its position in shares of MAXIMUS, Inc. (NYSE:MMS) by 4.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 587,844 shares of the health services provider’s stock after selling 25,108 shares during the period. MAXIMUS comprises 2.6% of Alta Capital Management LLC’s portfolio, making the stock its 18th biggest position. Alta Capital Management LLC owned about 0.90% of MAXIMUS worth $42,077,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Stephens Inc. AR increased its holdings in shares of MAXIMUS by 0.9% in the second quarter. Stephens Inc. AR now owns 6,638 shares of the health services provider’s stock valued at $416,000 after purchasing an additional 61 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. increased its holdings in shares of MAXIMUS by 0.5% in the second quarter. Los Angeles Capital Management & Equity Research Inc. now owns 16,932 shares of the health services provider’s stock valued at $1,060,000 after purchasing an additional 80 shares in the last quarter. Public Employees Retirement System of Ohio increased its holdings in shares of MAXIMUS by 0.3% in the second quarter. Public Employees Retirement System of Ohio now owns 73,252 shares of the health services provider’s stock valued at $4,588,000 after purchasing an additional 207 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of MAXIMUS by 10.2% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,367 shares of the health services provider’s stock valued at $148,000 after purchasing an additional 220 shares in the last quarter. Finally, Acrospire Investment Management LLC increased its holdings in shares of MAXIMUS by 17.6% in the second quarter. Acrospire Investment Management LLC now owns 2,000 shares of the health services provider’s stock valued at $125,000 after purchasing an additional 300 shares in the last quarter. 94.79% of the stock is owned by institutional investors.
Shares of MAXIMUS, Inc. (MMS) traded down $1.28 during trading on Thursday, hitting $69.97. 630,800 shares of the company were exchanged, compared to its average volume of 431,627. The firm has a market capitalization of $4,640.98, a price-to-earnings ratio of 22.00, a P/E/G ratio of 2.67 and a beta of 1.34. MAXIMUS, Inc. has a fifty-two week low of $51.74 and a fifty-two week high of $72.71.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 28th. Investors of record on Thursday, February 15th will be issued a $0.045 dividend. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.26%. The ex-dividend date of this dividend is Wednesday, February 14th. MAXIMUS’s dividend payout ratio is currently 5.66%.
In other MAXIMUS news, CEO Richard A. Montoni sold 30,000 shares of MAXIMUS stock in a transaction on Thursday, December 7th. The shares were sold at an average price of $69.25, for a total transaction of $2,077,500.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, General Counsel David Francis sold 3,900 shares of MAXIMUS stock in a transaction on Monday, November 13th. The stock was sold at an average price of $63.97, for a total transaction of $249,483.00. Following the sale, the general counsel now directly owns 15,090 shares of the company’s stock, valued at approximately $965,307.30. The disclosure for this sale can be found here. In the last three months, insiders sold 71,417 shares of company stock valued at $4,902,785. 3.10% of the stock is currently owned by company insiders.
A number of brokerages recently weighed in on MMS. Zacks Investment Research raised shares of MAXIMUS from a “sell” rating to a “hold” rating in a report on Wednesday. Canaccord Genuity reissued a “buy” rating on shares of MAXIMUS in a report on Wednesday, December 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $65.60.
TRADEMARK VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/01/18/maximus-inc-mms-stake-decreased-by-alta-capital-management-llc.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MAXIMUS, Inc. (NYSE:MMS).
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.